How a Molecular Diagnostic Company Enhanced Data Quality with Scispot's alt-SDMS

Company Overview

• Company: Molecular Diagnostic Company.
• Headquarters: Canada.
• Industry: Molecular Diagnostics.
• Plan: Scispot Professional.

Challenges

The company struggled with operational inefficiencies that threatened data integrity:

• Inconsistent Data Quality: Manual entry and disparate systems led to transcription mistakes and duplicate entries.
• High Data Volume: Processing 700 samples daily required a robust system to maintain integrity at scale.
• Poor System Integration: Existing EMRs, lab instruments, QMS, and ERP systems were siloed, causing significant workflow inefficiencies.
• Regulatory Compliance: Ensuring adherence to industry standards was difficult due to the lack of centralized, traceable data.

The Scispot Solution

Scispot implemented a customizable SDMS tailored to the specific needs of molecular diagnostics:

• Automated Data Integration: Integrated disparate platforms (EMR, instruments, QMS, ERP) into a unified system.
• Real-Time Validation: Implemented automated checks that flag errors at the point of entry.
• Scientific Ontology Management: Enabled structured data indexing, allowing for superior data organization and discovery.

Impact and Results

The implementation yielded significant performance gains:

• 95% Customer Satisfaction: Enhanced speed and accuracy of diagnostic results led to greater trust among physicians and patients.
• 70% Reduction in Data Entry Errors: Automated integration and real-time validation minimized manual transcription and duplicate entries.
• Operational Edge: The company achieved full data indexing, allowing the team to focus on research rather than data wrangling.

Expert Testimonial

"Scispot's alt-SDMS has upgraded our lab operations. The customizable SDMS system tailored to our needs has drastically improved our data quality... This has improved our data organization, retrieval, and discovery, allowing us to focus more on research and delivering high-quality diagnostics."— Chief Technology Officer, Molecular Diagnostic Company

‍

‍